Vertex Pharmaceuticals SG&A Expense (Quarterly) Analysis

Vertex Pharmaceuticals Inc (VRTX)

397.70 -3.06 (-0.76%) USD | NASDAQ | Apr 25, 16:00

394.00 -3.70 (-0.93%) Pre-Market: 08:39

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1991. Upgrade now.

Date	Value
December 31, 2023	369.10M
September 30, 2023	263.80M
June 30, 2023	262.60M
March 31, 2023	241.10M
December 31, 2022	267.40M
September 30, 2022	246.80M
June 30, 2022	215.30M
March 31, 2022	215.20M
December 31, 2021	255.20M
September 30, 2021	198.20M
June 30, 2021	194.60M
March 31, 2021	192.10M
December 31, 2020	211.89M
September 30, 2020	184.55M
June 30, 2020	191.80M
March 31, 2020	182.26M
December 31, 2019	195.28M
September 30, 2019	159.67M
June 30, 2019	156.50M
March 31, 2019	147.04M
December 31, 2018	153.21M
September 30, 2018	137.30M
June 30, 2018	137.30M
March 31, 2018	129.81M
December 31, 2017	134.79M

Date	Value
September 30, 2017	120.71M
June 30, 2017	127.25M
March 31, 2017	113.33M
December 31, 2016	109.91M
September 30, 2016	106.06M
June 30, 2016	111.65M
March 31, 2016	105.21M
December 31, 2015	96.55M
September 30, 2015	99.77M
June 30, 2015	94.39M
March 31, 2015	85.86M
December 31, 2014	78.53M
September 30, 2014	75.22M
June 30, 2014	77.45M
March 31, 2014	74.21M
December 31, 2013	73.06M
September 30, 2013	86.43M
June 30, 2013	106.52M
March 31, 2013	92.88M
December 31, 2012	106.34M
September 30, 2012	97.68M
June 30, 2012	117.51M
March 31, 2012	111.15M
December 31, 2011	121.88M
September 30, 2011	110.65M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

156.50M

Minimum

Jun 2019

369.10M

Maximum

Dec 2023

221.23M

Average

211.89M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks